New research shows that masitinib limits neuronal damage in a model of neuroimmune-driven neurodegenerative disease
13/03/2024 – AB Science today announced the publication of new preclinical results for masitinib in neurodegenerative diseases
Summary of the live webcast held on March 4, 2024, providing an update on AB Science development
07/03/2024 – AB Science is providing a summary of the live webcast held on March 4, 2024, giving an update on AB Science development
Two financial analysis firms initiate coverage of AB Science
06/03/2024 – AB Science announces that two financial analysis firms, DNA Finance and In Extenso Finance, have initiated coverage of the Company
AB Science webcast of March 4, 2024
04/03/2024 – Presentation of the AB Science webcast held on March 4, 2024
Live webcast on Monday March 4, 2024, from 6.30pm to 7.30pm CET
01/03/2024 – AB Science will host a live webcast on Monday March 4, 2024, from 6.30pm to 7.30pm CET